Cathay Biotech Inc.’s Net Profit Dropped 28.2% in First Half of 2023

Cathay Biotech Inc. (上海凯赛生物技术股份有限公司) (688065.SH) reported a net profit of 264.5 million yuan in the first half of 2023, down 28.2% year-on-year.

Meanwhile, the company posted 1 billion yuan in revenue, down 20.1% year-on-year.

At the end of the reporting period, it had 18.5 billion yuan in total assets and 3.3 billion yuan in total liabilities, with a liability-to-asset ratio of 17.8%.